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INTRODUCTION
Progress in development of vitreous surgery has
allowed vitrectomy to be performed to treat dia-
betic macular edema. Efficacy of such a treatment
was discussed in many reports, and the procedure
is now almost well established (1-3). However, mas-
sive hard exudates with diabetic macular edema are
still difficult to manage, and good visual prognosis
cannot be expected using ordinary vitrectomy (4, 5).
Submacular hard exudates can be removed by vitrec-
tomy through a transretinal approach. However, in-
formation regarding vitreoretinal surgery for re-
moving massive hard exudates is minimal, and only
small case series exist (6 - 8). In contrast to previous
reports, our present case series consisted of 56 eyes
from 40 patients. We evaluated outcomes of our vit-
reous surgery to remove massive hard exudates with
diabetic macular edema.
PATIENTS AND METHODS
Patients
A consecutive series of 40 patients with massive
diabetic macular hard exudates who underwent sub-
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macular surgery were retrospectively reviewed.
Fifty-six eyes of 40 consecutive patients with mas-
sive diabetic macular hard exudates underlying the
fovea were entered into this study. All patients un-
derwent initial vitreous surgery to remove massive
hard exudates, at the Tokushima University Hos-
pital between April 1996 and February 2002. All sur-
gical procedures were performed by one surgeon
(TN). Informed consent was obtained from each
patient before surgery. Twenty - four patients were
treated in one eye, and the residual 16 patients were
treated in both eyes. Patients included 20 women
(26 eyes), and 20 men (30 eyes) ranging from 44 to
75 years old (mean ageSD, 58.98.5 years old).
All patients had received panretinal photocoagula-
tion in the affected eyes.
Preoperative records included age, gender, af-
fected eye, duration of symptoms, visual acuity in
decimal, fundus findings, size of exudates ( greatest
diameter ) and hemoglobin A1C (HbA1C) obtained
within 3 months before surgery. Postoperative re-
cords included visual acuity, fundus findings, dura-
tion of follow -up and postoperative complications.
All patients were followed for more than 1 year post-
operatively.
Surgical Techniques
Surgical procedures were almost the same as
those for vitreous surgery for age - related macular
degeneration (9, 10). A standard three -port pars
plana vitrectomy (PPV) was performed, and the
posterior adherent cortical vitreous was removed
from the retina when posterior vitreous detachment
was not present preoperatively. A small retinotomy
was performed at the easiest point to access the
hard exudates. Subretinal infusion through the ret-
inotomy hole was done to create macular detach-
ment, and the hard exudates were removed using
a subretinal forceps, and washed out by careful
subretinal infusion. After removal of the hard exu-
dates, a fluid -gas exchange with air or perfluoro-
propane gas was performed to remove the subreti-
nal fluid, and the retina was re - attached. Surgery-
combined pars plana lensectomy with intraocular
lens implantation was performed in 40 eyes. Four
eyes were previously operated for cataract. Lenses
were kept in 12 eyes.
Statistical Analyses
All statistical procedures were performed using
the SPSS 13.0 for Windows software (SPSS Japan
Inc., Tokyo, Japan). At time of surgery, age, preop-
erative duration, visual acuity, size of exudates and
HbA1C were recorded for each eye. All eyes were
classified into 2 groups according to postoperative
best visual acuity : group A, postoperative best vis-
ual acuity of 0.3 or better ; and group B, postopera-
tive best visual acuity worse than 0.3. A comparative
statistical analysis was done among these 2 groups.
RESULTS
Twenty women (26 eyes) and 20 men (30 eyes)
were included in this study. Their age ranged from
44 to 75 years old (mean ageSD, 58.98.5). The
follow -up period ranged from 12 to 91 months
(mean SD, 43.6 22.3). All patients had type 2
diabetes mellitus (DM). Posterior vitreous detach-
ment was not observed in 54 (96.4%) of 56 eyes
during vitrectomy. One eye needed a second sur-
gery. After the first surgery, hard exudates accu-
mulated again. We performed a second surgery for
the affected eye 6 months later, to remove the hard
exudates and an epiretinal membrane. In all patients,
macular hard exudates in the fovea almost disap-
peared, and macular edema was remarkably reduced
after surgery. Representative cases are shown in
Figures 1 and 2.
Characteristics of patients are summarized in
Table 1. Preoperative duration after onset of blurred
vision ranged from 2.0 to 48.0 months (meanSD,
10.47.3), including that in 43 eyes (76.8%) of 12.0
months or less. Hemoglobin A1C (HbA1C) obtained
within 3 months before surgery ranged from 5.1 to
12.3% (meanSD, 7.11.3). Preoperative decimal
visual acuity ranged from 0.01 to 0.3 (meanSD,
0.1050.069), and 40 of 56 eyes (71.4%) were 0.1
or less. Postoperative best visual acuity ranged
from 0.04 to 1.0, and it was 0.3 or better in 24 of 56
eyes (42.9%). Postoperative best visual acuity im-
proved by 2 lines or better in 45 eyes (80.4%), re-
mained unchanged in 8 eyes (14.3%), and deterio-
rated in 3 eyes (5.3%) (P0.0001, using a Student’s
t -test for paired data, Figure 3). Follow -up period
to resume the best visual acuity ranged from 1.0 to
65.5 months (mean SD, 12.9 11.5). Postopera-
tive final visual acuity improved by 2 lines or bet-
ter in 39 eyes (69.7%), remained unchanged in 11
eyes (19.6%), and deteriorated in 6 eyes (10.7%) (P =
0.0016, using a Student’s t - test for paired data,
Figure 4).
Characteristics of the 2 groups are summarized
in Table 2. For postoperative best visual acuity re-
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sults, the better postoperative visual acuity (0.3 or
better) was related to HbA1C (P =0.004 using a
Student’s t - test), and to size of hard exudates (P =
0.026 using a Student’s t -test).
Complications related to surgery were observed in
14 eyes. Retinal tear formed in 7 of 56 eyes (12.5%).
Figure 3. Scattergram of preoperative visual acuity and postop-
erative best visual acuity.
Postoperative best visual acuity improved 2 lines or better in 45
eyes (80.4%), remained unchanged in 8 eyes (14.3%) and dete-
riorated in 3 eyes (5.3%) (p0.0001).
Table 1. Characteristics of Patients
No. of patients 40
Unilateral 24
Bilateral 16
No. of eyes 56
Sex
Female 20 (26 eyes)
Male 20 (30 eyes)
Age (yrs)
Range 44 - 75
Mean 58.9
SD 8.5
Preoperative Duration (mos)
Range 2 - 48
Mean 10.4
SD 7.3
HbA1C (%)
Range 5.1 - 12.3
Mean 7.1
SD 1.3
Preoperative VA
Range 0.01 - 0.3
Mean 0.105
SD 0.069
SD=standard deviation
VA=visual acuity
A B C
Figure 1. A, A 51-year-old female before surgery. A preoperative fundus appearance of massive macular hard exudates. The
preoperative visual acuity was 0.01. B, Five months after surgery, macular hard exudates have almost disappeared and visual acuity
improved to 0.4. C, Twenty-seven months after surgery, macular hard exudates disappeared and visual acuity improved to 1.0.
A B C
Figure 2. A, A 57-year-old female before surgery. A preoperative fundus appearance of massive macular hard exudates. The
preoperative visual acuity was 0.1. B, Four months after surgery, macular hard exudates almost disappeared and visual acuity im-
proved to 0.6. C, Sixty-five months after surgery, macular hard exudates disappeared and visual acuity improved to 1.0.
The Journal of Medical Investigation Vol. 55 August 2008 213
A macular hole was made during the creation of
macular detachment in 3 eyes. An increase in lens
nuclear sclerosis was observed in 4 eyes of phakic
patients postoperatively. All these complications
did not cause any serious problems because of our
proper procedures during surgery.
DISCUSSION
Vitrectomy has been performed for diabetic
macular edema. Efficacy of such a treatment was
discussed in many reports, and the standard pro-
cedure is now almost well established (1 - 3). How-
ever, massive hard exudates with diabetic macular
edema are still difficult to manage and good visual
prognosis cannot be expected using ordinary vitrec-
tomy (4, 5). In previous cases of diabetic macular
edema, hard exudates remained and visual prog-
nosis was not good after vitrectomy. Following re-
cent advances in vitreous surgery, hard exudates
can now be removed using a transretinal approach,
just like in vitreous surgery for age - related macu-
lar degeneration (9, 10). Therefore, we believed that
this procedure might be useful for cases of diabetic
macular edema and used this technique in 56 eyes
after getting informed consent from appropriate pa-
tients. However, previous information on vitreoreti-
nal surgery for removing massive hard exudates is
minimal and only small case series have been re-
ported (6 -8), including at the most 10 cases. In
contrast to previous reports including only small
numbers, our series consisted of 56 eyes of 40 pa-
tients.
In this series, 40 eyes (71%) had a preoperative
visual acuity of 0.1 or less. Postoperatively, 24 eyes
(43%) had a best visual acuity of 0.3 or better. Seven
eyes (13%) had a postoperative best visual acuity of
0.5 or better. In other reports (6 - 8), visual outcome
was not as good as ours and number of cases was
smaller than ours.
Several factors might have created favorable sur-
gical outcomes in our patients undergoing removal
of subfoveal massive hard exudates. Firstly, preop-
erative durations of symptoms were relatively short,
and were 12 months or shorter in 43 eyes (77%). It
is difficult to determine the optimal period of ob-
servation time before removal of the massive hard
exudates. However, in order to obtain better surgi-
cal outcomes, we should attempt to perform sub-
macular surgery at the beginning of accumulation
of the hard exudates under the fovea. Therefore,
we can prevent irreversible retinal damage caused
by hard exudates. Secondly, in our procedure, the
subretinal space was washed with an infusion solu-
tion after submacular hard exudates were removed.
Using this procedure, vascular endothelial growth
factor (VEGF) or some cytokines playing a key role
in the pathogenesis of diabetic macular edema are
washed out from the subretinal space. VEGF is be-
Figure 4. Scattergram of preoperative visual acuity and postop-
erative final visual acuity.
Postoperative final visual acuity improved 2 lines or better in 39
eyes (69.7%), remained unchanged in 11 eyes (19.6%) and dete-
riorated in 6 eyes (10.7%) (p = 0.0016).
Table 2. Characteristics of Groups
Group A Group B
(VA0.3) (VA<0.3)
No. of eyes 24 32
Age (yrs)
Range 47 - 75 44 - 74
Mean 57.7 59.8
SD 8.1 8.8
HbA1C (%)*
Range 5.2 - 8.5 5.1 - 12.3
Mean 6.50 7.47
SD 0.86 1.38
Preoperative Duration (mos)
Range 2 - 24 2 - 48
Mean 8.6 11.8
SD 5.03 8.79
Size of Exudate (DD)*
Range 0.5 - 1.5 0.3 - 3.5
Mean 0.86 1.32
SD 0.34 0.94
Duration for Absorption (mos)
Range 3 - 19.4 2 - 19.2
Mean 7.03 8.91
SD 3.91 4.61
VA = visual acuity
SD = standard deviation
DD= disc diameter
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lieved to be an important factor to create hard exu-
dates and it has been detected in excised specimens
of diabetic macular hard exudates using immuno-
histochemical staining (6). Thirdly, we tried to re-
move hard exudates as gently as we could, with
great delicacy. Most of the hard exudates were
washed out with the infusion solution to prevent
damaging the neural retina and the pigment epi-
thelium. Hard exudates are known to exist in the
outer plexiform layer of the retina. However, in
cases with massive hard exudates, they form in the
subretinal space. Therefore, we could wash out most
of them using the infusion solution.
Statistical results showed that good visual prog-
nosis (0.3 or better) was related to HbA1C and to
the size of the hard exudates. Some reports sug-
gested a correlation between glycemic control and
diabetic retinopathy (11, 12). One study reported a
correlation between persistent clinically significant
macular edema (CSME) and elevated HbA1C, and
that persistent CSME occurred more frequently
when HbA1C was greater than 7.5% (13). In our
report, mean HbA1C was 7.47% in the worse visual
prognosis (less than 0.3) group. This suggested the
importance of glycemic control in the management
of DM. Good visual prognosis also correlates with
size of hard exudates, since size of hard exudates
may correspond to severity of macular edema and
retinopathy.
Since the advent of nuclear cataract following
vitrectomy within a few years, we performed len-
sectomy combined with intraocular lense implan-
tation at the time of our submacular surgery in 39
eyes (70%).
Our surgical outcomes showed that submacular
surgery was effective and safe in removing macu-
lar hard exudates from diabetic patients.
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